BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3283176)

  • 1. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open trial of imipenem/cilastatin therapy for serious bacterial infections.
    Brooks RG; McCabe RE; Vosti KL; Remington JS
    Rev Infect Dis; 1985; 7 Suppl 3():S496-505. PubMed ID: 3901213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
    Calandra GB; Hesney M; Grad C
    Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem/cilastatin: general experience in a community hospital.
    Iannini PB; Kunkel MJ; Hilton E; Iannini GM
    Am J Med; 1985 Jun; 78(6A):122-6. PubMed ID: 3859211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.
    Wang C; Calandra GB; Aziz MA; Brown KR
    Rev Infect Dis; 1985; 7 Suppl 3():S528-36. PubMed ID: 3901217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of imipenem/cilastatin on the colonic microflora.
    Nord CE; Kager L; Philipson A; Stiernstedt G
    Rev Infect Dis; 1985; 7 Suppl 3():S432-4. PubMed ID: 3863218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/cilastatin: a multicentre international study of its clinical efficacy, safety and potential as empirical therapy.
    Wang C; Pappas F; Cook T
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():185-91. PubMed ID: 3469193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients.
    Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; Antúnez de Mayolo E
    Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonia treated with imipenem/cilastatin.
    Salata RA; Gebhart RL; Palmer DL; Wade BH; Scheld WM; Groschel DH; Wenzel RP; Mandell GL; Duma RJ
    Am J Med; 1985 Jun; 78(6A):104-9. PubMed ID: 3859208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early clinical experience with imipenem-cilistatin.
    Ellis-Pegler RB; Downey D; Bremner DA
    N Z Med J; 1985 Mar; 98(775):188-91. PubMed ID: 3856762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
    Wang C; Pappas F; Cook T
    Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
    Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
    Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.